Skip to content
Loading…
Johnson & Johnson CEO Joaquin Duato says the company has no plans to enter the obesity market, instead focusing on areas such as cancer. He says oncology remains one of J&J's core growth pillars, and highlights dementia as another major challenge for the healthcare industry.…
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.